Sun Pharmaceutical Industries share price closes at ₹1,840; falls 1.13% on September 11
Varda Khade
- 0 min read
Last Updated: 11th September 2026 - 06:18 pm
Key Takeaways
- Sun Pharmaceutical Industries declined ₹21 or 1.13% to ₹1,840 after trading through a ₹21 session range.
- The close remained above the 200-day DMA of ₹1,823.30 but below the 50-day and 100-day moving averages.
- Its one-year return stood at 15.48%, while six months and three months were positive at 1.50% and 3.00%.
Sun Pharmaceutical Industries share price ended September 11 at ₹1,840, down ₹21 or 1.13% from the previous close of ₹1,861. It opened at ₹1,845 and reached ₹1,855 before falling to a session low of ₹1,834.
The high-low distance was ₹21, identical in rupee terms to the headline decline. Sun Pharma finished ₹6 above the low and ₹15 below its high. Compared with the opening price, the stock closed ₹5 lower. Volume reached 1,540,686 shares. Market capitalisation stood at ₹4,41,478 crore.
The closing price remained above its 200-day DMA but below the shorter averages. At ₹1,823.30, the 200-day DMA was ₹16.70 beneath the close. The 100-day DMA stood at ₹1,874.90, leaving a ₹34.90 gap. Its 50-day DMA was ₹1,907, which was ₹67 above the final value.
Sun Pharma’s 52-week range ran from ₹1,548 to ₹2,047. The ₹1,840 close was ₹292 above the low and ₹207 below the high. The complete annual spread amounted to ₹499. September 11’s intraday high remained ₹192 below the 52-week peak.
Longer-period performance was mixed but positive beyond one month. The one-month return stood at -5.37%. Three months was 3.00%, six months 1.50% and one year 15.48%. The one-year return was 12.48 percentage points above the three-month figure. September 11’s decline therefore came while the displayed six-month and one-year readings remained on the positive side, and while the closing price still sat above the 200-day DMA.
Frequently Asked Questions
What was the Sun Pharmaceutical Industries share price on September 11?
How did Sun Pharma close relative to its DMAs?
What were Sun Pharma’s recent returns?
- Flat ₹20 Brokerage
- Next-gen Trading
- Advanced Charting
- Actionable Ideas
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.